|
Feb. 08, 2018 |
|
|
Mar. 18, 2019 |
|
|
jRCT1090220328 |
An effectiveness study of a continuous approach from routine intrapartum care to emergency obstetric care on reducing severe maternal outcomes: A stepped-wedge cluster randomized control trial in Lao P.D.R (CARE Trial: Continuous Approach on improving Routine care in childbirth and Emergency obstetric care) |
|
An effectiveness study of a continuous approach from routine intrapartum care to emergency obstetric care on reducing severe maternal outcomes through nation-wide rollout in Lao PDR |
Shogo Kubota |
||
World Health Orgnization |
||
Ban Phonxay, That Luang Road, Vientiane, Lao P.D.R. |
||
856-214-413431 |
||
kubotas@who.int |
||
Shogo Kubota |
||
World Health Orgnization |
||
Ban Phonxay, That Luang Road, Vientiane, Lao P.D.R. |
||
856-21-413431 |
||
kubotas@who.int |
PENDING |
May. 01, 2018 |
||
| 576 | ||
Interventional |
||
Stepped-wedge cluster randomized control trial |
||
single blind |
||
Yes |
||
N/A |
||
Women who was diagnosed as pre-eclampsia, eclampsia, postpartum hemorrhage, perinatal infection or other maternal complication in the target hospitals within the study period |
||
None |
||
| No limit | ||
| No limit | ||
Female |
||
Severe pre-eclampsia, eclampsia, postpartum hemorrhage, perinatal maternal infection, and other maternal severe outcome cases |
||
Intervention type: Name of intervention:Package on improving continuous care in childbirth and emergency obstetric care Dose form / Japanese Medical Device Nomenclature:NOT APPLICABLE Route of administration / Site of application: Dose per administration:5 days N/A day Dosing frequency / Frequency of use:ONCE N/A Planned duration of intervention:4 months Intended dose regimen:N/A detailes of teratment arms:Training on continuous care in childbirth and emergency obstetric care ? 3 days, and audit and feedback after 3 months ? 2 days Comparative intervention name:No intervention Dose form / Japanese Medical Device Nomenclature:NOT APPLICABLE Route of administration / Site of application: Dose per administration:N/A N/A N/A Dosing frequency / Frequency of use: N/A Planned duration of intervention:N/A Intended dose regimen:N/A |
||
Risk of severe maternal outcomes among those with complications |
||
Quality of care for severe pre-eclampsia, eclampsia, postpartum hemorrhage |
||
| University of Tokyo | |
| Ministry of Health, University of Health Science in Laos, WHO |
| none |
| Office for Human Research Studies, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo | |
+81-3-5841-0818 |
|
| http://u-tokyo-ohrs.jp/ | |
| Yes | |
| applying |
| N/A | |
| N/A |
| JMA-IIA00328 | |